Affymetrix Inc. and PathWork Informatics Inc. have announced that Affymetrix has granted PathWork long-term non-exclusive access to its microarray technology to develop and market in-vitro diagnostic ...

REDWOOD CITY, Calif.--(BUSINESS WIRE)-- Pathwork Diagnostics, Inc., a pioneer in creating genomics-based diagnostics in oncology utilizing their proprietary informatics platform, today announced the ...

SAN FRANCISCO, Oct. 20, 2025 /PRNewswire/ -- Pathwork, the AI-native platform modernizing the $160 billion life and health insurance market, today announced a strategic partnership with AIMCOR Group, ...

Are you or someone you care about wondering if therapy might be helpful? Maybe you've thought, "I don't want to feel like this anymore, but I don't know what to do," or "Something just doesn’t feel ...

Whether you’re a teenager, or raising one, adolescence is no joke. This transitional period can test relationship limits and leave teens and parents feeling hurt, confused, scared, and an array of ...

SUNNYVALE, Calif., July 31 /PRNewswire/ -- Pathwork Diagnostics, Inc., a molecular diagnostics company focused on oncology, today announced that the U.S. Food and Drug Administration (FDA) has cleared ...

SAN FRANCISCO and MADISON, Wis., March 5, 2026 /PRNewswire/ -- Pathwork and NGL Insurance Company (NGL), in partnership with LifeCare Assurance Company, announced the launch of PreQual Manager, an ...

"On behalf of Pathwork's board and investors, I am delighted to welcome Mr. McCracken to the Pathwork team," said Peter Klemm, Ph.D., Chairman of the Board. "Lee, with his considerable leadership and ...

Microarray-based assay can be used on FFPE samples to help identify primary tumor site. Pathwork Diagnostics raised $30 million in a Series C financing round led by Alta Partners. Existing investors ...

Pathwork Diagnostics, a Sunnyvale, Calif.-based maker of cancer diagnostic tets, has raised $20 million in a second round of funding. The round was led by new investor Abingworth Management, with ...